Marine-Derived Fungal Metabolites References 785
Part F | 32
tubule agent: Correlation of neutropenia with
time above a threshold serum concentration,
Proc. Am. Soc. Clin. Oncol. 22, 516 (2003)
32.62
B.A. Hadaschik, S. Ettinger, R.D. Sowery,
A. Zoubeidi, R.J. Andersen, M. Roberge,
M.E. Gleave: Targeting prostate cancer with
HTI-286, a synthetic analogue of the marine
sponge product hemiasterlin, Int. J. Cancer 122,
2368–2376 (2008)
32.63
G.R. Pettit, C.L. Herald, D.L. Doubek, D.L. Herald, E. Arnold, J. Clardy: Isolation and structure of
bryostatin 1, J. Am. Chem. Soc. 104, 6846–6848
(1982)
32.64
G.R. Pettit: Progress in the discovery of biosynthetic anticancer drugs, J. Nat. Prod. 59, 812–821
(1996)
32.65
M.A. Rouhi: Supply issues complicate track of
chemicals from sea to market, Chem. Eng. News
73, 42–44 (1995)
32.66
L.H. Cragg, M. Andreeff, E. Feldman, J. Roberts,
A. Murgo, M. Winning, M.B. Tombes, G. Roboz,
L. Kramer, S. Grant: Phase I trial and correlative laboratory studies of bryostatin 1 (NSC 339555)
and high-dose 1-ˇ-D-arabinofuranosylcytosine
in patients with refractory acute leukemia, Clin.
Cancer Res. 8, 2123–2133 (2002)
32.67
A. Dowlati, H.M. Lazarus, P. Hartman, J.W. Jacobberger, C. Whitacre, S.L. Gerson, P. Ksenich,
B.W. Cooper, P.S. Frisa, M. Gottlieb, A.J. Murgo,
S.C. Remick: Phase I and correlative study of combination bryostatin 1 and vincristine in relapsed
B-cell malignancies, Clin. Cancer Res. 9, 5929–
5935 (2003)
32.68
J.A. Ajani, Y. Jiang, J. Faust, B.B. Chang, L. Ho,
J.C. Yao, S. Rousey, S. Dakhil, R.C. Cherny, C. Craig,
A. Bleyer: A multi-center phase II study of sequential paclitaxel and bryostatin 1 (NSC 339555)
in patients with untreated, advanced gastric or
gastroesophageal junction adenocarcinoma, Investig. New Drugs 24, 353–357 (2006)
32.69
A.M.S. Mayer, K.R. Gustafson: Marine pharmacology in 2005–2006: Antitumor and cytotoxic
compounds, Eur. J. Cancer 44, 2357–2387 (2008)
32.70
A.M.S. Mayer, A.D. Rodríguez, R.G.S. Berlinck,
M.T. Hamann: Marine pharmacology in 2005–
6: Marine compounds with anthelmintic,
antibacterial, anticoagulant, antifungal, antiinflammatory,
antimalarial,
antiprotozoal,
antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous
systems, and other miscellaneous mechanisms
of action, Biochim. Biophys. Acta 1790, 283–402
(2009)
32.71
M.S. Laport, O.C.S. Santos, G. Muricy: Marine
sponges: Potential sources of new antimicrobial
drugs, Curr. Pharm. Biotechnol. 10, 86–105 (2009)
32.72
A. Staniek, H.J. Woerdenbag, O. Kayser: Taxomyces
andreanae: A presumed paclitaxel producer demystified?, Planta Medica 75, 1561–1566 (2009)
32.73
T. Amna, S.C. Purl, V. Verma, J.P. Sharma,
R.K. Khajuria, J. Musarrat, M. Spiteller, G.N. Qazi:
Bioreactor studies on the endophytic fungus Entrophospora infrequens for the production of an
anticancer alkaloid camptothecin, Can. J. Microbiol. 52, 189–196 (2006)
32.74
V. Rukachaisirikul, N. Khamthong, Y. Sukpondma,
C. Pakawatchai, S. Phongpaichit, J. Sakayaroj,
K. Kirtikara: An [11]cytochalasin derivative from
the marine-derived fungus Xylaria sp. PSU-F100,
Chem. Pharm. Bull. 57, 1409–1411 (2009)
32.75
Z. Chen, H. Huang, Y. Chen, Z. Wang, J. Ma,
B. Wang, W. Zhang, C. Zhang, J. Ju: New cytochalasins from the marine-derived fungus Xylaria sp.
SCSIO 156, Helv. Chim. Acta 94, 1671–1676 (2011)
32.76
S.A. Neff, S.U. Lee, Y. Asami, J.S. Ahn, H. Oh, J. Baltrusaitis, J.B. VGloer, D.T. Wicklow: Aflaquinolones
A–G: secondary metabolites from marine and
fungicolous isolates of Aspergillus spp., J. Nat.
Prod. 75, 464–472 (2012)
32.77
D. Zhang, M. Satake, S. Fukuzawa, K. Sugahara, A. Niitsu, T. Shirai, K. Tachibana: Two
new indole alkaloids, 2-(3,3-dimethylprop-1ene)-costaclavine and 2-(3,3-dimethylprop-1ene)-epicostaclavine, from the marine-derived
fungus Aspergillus fumigatus, J. Nat. Med. 66,
222–226 (2012)
32.78
L. Ding, H.-M. Dahse, C. Hertweck: Cytotoxic alkaloids from Fusarium incarnatum associated with
the mangrove tree Aegiceras coniculatum, J. Nat.
Prod. 75, 617–621 (2012)
32.79
C. Almeida, N. Part, S. Bouhired, S. Kehraus,
G.M. König: Stachylines A–D from the spongederived fungus Stachylidium sp., J. Nat. Prod. 74,
21–25 (2011)
32.80
C.-S. Li, C.-Y. An, X.-M. Li, S.-S. Gao, C.-M. Cui,
H.-F. Sun, B.-G. Wang: Triazole and dihydroimidazole alkaloids from the marine sedimentderived fungus Penicillium paneum SD-44, J. Nat.
Prod. 74, 1331–1334 (2011)
32.81
F. Zhu, G. Chen, X. Chen, M. Huang, X. Wan: Aspergicin, a new antibacterial alkaloid produced
by mixed fermentation of two marine-derived
mangrove epiphytic fungi, Chem. Nat. Comp. 47,
767–769 (2011)
32.82
E. Julianti, H. Oh, H.-S. Lee, D.-C. Oh, K.-B. Oh,
J. Shin: Acremolin, a new 1H-azirine metabolite from the marine-derived fungus Acremonium strictum, Tetrahedron Lett. 53, 2885–2886
(2012)
32.83
C. Almeida, Y. Hemberger, S.M. Schmitt,
S. Bouhired, L. Natesan, S. Kehraus, K. Dimas, M. Gütschow, G. Bringmann, G.M. König:
Marilines A–C: novel phthalimidines from the
sponge-derived fungus Stachylidium sp., Chem.
Eur. J. 18, 8827–8834 (2012)
32.84
W.C. Groustas, D. Dou, K.R. Alliston: Neutrophil
elastase inhibitors, Expert Opin. Therap. Patents
21, 339–354 (2011)
Part F | 32
tubule agent: Correlation of neutropenia with
time above a threshold serum concentration,
Proc. Am. Soc. Clin. Oncol. 22, 516 (2003)
32.62
B.A. Hadaschik, S. Ettinger, R.D. Sowery,
A. Zoubeidi, R.J. Andersen, M. Roberge,
M.E. Gleave: Targeting prostate cancer with
HTI-286, a synthetic analogue of the marine
sponge product hemiasterlin, Int. J. Cancer 122,
2368–2376 (2008)
32.63
G.R. Pettit, C.L. Herald, D.L. Doubek, D.L. Herald, E. Arnold, J. Clardy: Isolation and structure of
bryostatin 1, J. Am. Chem. Soc. 104, 6846–6848
(1982)
32.64
G.R. Pettit: Progress in the discovery of biosynthetic anticancer drugs, J. Nat. Prod. 59, 812–821
(1996)
32.65
M.A. Rouhi: Supply issues complicate track of
chemicals from sea to market, Chem. Eng. News
73, 42–44 (1995)
32.66
L.H. Cragg, M. Andreeff, E. Feldman, J. Roberts,
A. Murgo, M. Winning, M.B. Tombes, G. Roboz,
L. Kramer, S. Grant: Phase I trial and correlative laboratory studies of bryostatin 1 (NSC 339555)
and high-dose 1-ˇ-D-arabinofuranosylcytosine
in patients with refractory acute leukemia, Clin.
Cancer Res. 8, 2123–2133 (2002)
32.67
A. Dowlati, H.M. Lazarus, P. Hartman, J.W. Jacobberger, C. Whitacre, S.L. Gerson, P. Ksenich,
B.W. Cooper, P.S. Frisa, M. Gottlieb, A.J. Murgo,
S.C. Remick: Phase I and correlative study of combination bryostatin 1 and vincristine in relapsed
B-cell malignancies, Clin. Cancer Res. 9, 5929–
5935 (2003)
32.68
J.A. Ajani, Y. Jiang, J. Faust, B.B. Chang, L. Ho,
J.C. Yao, S. Rousey, S. Dakhil, R.C. Cherny, C. Craig,
A. Bleyer: A multi-center phase II study of sequential paclitaxel and bryostatin 1 (NSC 339555)
in patients with untreated, advanced gastric or
gastroesophageal junction adenocarcinoma, Investig. New Drugs 24, 353–357 (2006)
32.69
A.M.S. Mayer, K.R. Gustafson: Marine pharmacology in 2005–2006: Antitumor and cytotoxic
compounds, Eur. J. Cancer 44, 2357–2387 (2008)
32.70
A.M.S. Mayer, A.D. Rodríguez, R.G.S. Berlinck,
M.T. Hamann: Marine pharmacology in 2005–
6: Marine compounds with anthelmintic,
antibacterial, anticoagulant, antifungal, antiinflammatory,
antimalarial,
antiprotozoal,
antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous
systems, and other miscellaneous mechanisms
of action, Biochim. Biophys. Acta 1790, 283–402
(2009)
32.71
M.S. Laport, O.C.S. Santos, G. Muricy: Marine
sponges: Potential sources of new antimicrobial
drugs, Curr. Pharm. Biotechnol. 10, 86–105 (2009)
32.72
A. Staniek, H.J. Woerdenbag, O. Kayser: Taxomyces
andreanae: A presumed paclitaxel producer demystified?, Planta Medica 75, 1561–1566 (2009)
32.73
T. Amna, S.C. Purl, V. Verma, J.P. Sharma,
R.K. Khajuria, J. Musarrat, M. Spiteller, G.N. Qazi:
Bioreactor studies on the endophytic fungus Entrophospora infrequens for the production of an
anticancer alkaloid camptothecin, Can. J. Microbiol. 52, 189–196 (2006)
32.74
V. Rukachaisirikul, N. Khamthong, Y. Sukpondma,
C. Pakawatchai, S. Phongpaichit, J. Sakayaroj,
K. Kirtikara: An [11]cytochalasin derivative from
the marine-derived fungus Xylaria sp. PSU-F100,
Chem. Pharm. Bull. 57, 1409–1411 (2009)
32.75
Z. Chen, H. Huang, Y. Chen, Z. Wang, J. Ma,
B. Wang, W. Zhang, C. Zhang, J. Ju: New cytochalasins from the marine-derived fungus Xylaria sp.
SCSIO 156, Helv. Chim. Acta 94, 1671–1676 (2011)
32.76
S.A. Neff, S.U. Lee, Y. Asami, J.S. Ahn, H. Oh, J. Baltrusaitis, J.B. VGloer, D.T. Wicklow: Aflaquinolones
A–G: secondary metabolites from marine and
fungicolous isolates of Aspergillus spp., J. Nat.
Prod. 75, 464–472 (2012)
32.77
D. Zhang, M. Satake, S. Fukuzawa, K. Sugahara, A. Niitsu, T. Shirai, K. Tachibana: Two
new indole alkaloids, 2-(3,3-dimethylprop-1ene)-costaclavine and 2-(3,3-dimethylprop-1ene)-epicostaclavine, from the marine-derived
fungus Aspergillus fumigatus, J. Nat. Med. 66,
222–226 (2012)
32.78
L. Ding, H.-M. Dahse, C. Hertweck: Cytotoxic alkaloids from Fusarium incarnatum associated with
the mangrove tree Aegiceras coniculatum, J. Nat.
Prod. 75, 617–621 (2012)
32.79
C. Almeida, N. Part, S. Bouhired, S. Kehraus,
G.M. König: Stachylines A–D from the spongederived fungus Stachylidium sp., J. Nat. Prod. 74,
21–25 (2011)
32.80
C.-S. Li, C.-Y. An, X.-M. Li, S.-S. Gao, C.-M. Cui,
H.-F. Sun, B.-G. Wang: Triazole and dihydroimidazole alkaloids from the marine sedimentderived fungus Penicillium paneum SD-44, J. Nat.
Prod. 74, 1331–1334 (2011)
32.81
F. Zhu, G. Chen, X. Chen, M. Huang, X. Wan: Aspergicin, a new antibacterial alkaloid produced
by mixed fermentation of two marine-derived
mangrove epiphytic fungi, Chem. Nat. Comp. 47,
767–769 (2011)
32.82
E. Julianti, H. Oh, H.-S. Lee, D.-C. Oh, K.-B. Oh,
J. Shin: Acremolin, a new 1H-azirine metabolite from the marine-derived fungus Acremonium strictum, Tetrahedron Lett. 53, 2885–2886
(2012)
32.83
C. Almeida, Y. Hemberger, S.M. Schmitt,
S. Bouhired, L. Natesan, S. Kehraus, K. Dimas, M. Gütschow, G. Bringmann, G.M. König:
Marilines A–C: novel phthalimidines from the
sponge-derived fungus Stachylidium sp., Chem.
Eur. J. 18, 8827–8834 (2012)
32.84
W.C. Groustas, D. Dou, K.R. Alliston: Neutrophil
elastase inhibitors, Expert Opin. Therap. Patents
21, 339–354 (2011)